Tactile Systems Technology (Tactile Systems Technology) Debt-to-Equity : 0.26 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Debt-to-Equity?

Tactile Systems Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.8 Mil. Tactile Systems Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $44.6 Mil. Tactile Systems Technology's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $193.6 Mil. Tactile Systems Technology's debt to equity for the quarter that ended in Dec. 2023 was 0.26.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tactile Systems Technology's Debt-to-Equity or its related term are showing as below:

TCMD' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.22 Max: 0.63
Current: 0.26

During the past 11 years, the highest Debt-to-Equity Ratio of Tactile Systems Technology was 0.63. The lowest was 0.00. And the median was 0.22.

TCMD's Debt-to-Equity is ranked worse than
55.07% of 710 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs TCMD: 0.26

Tactile Systems Technology Debt-to-Equity Historical Data

The historical data trend for Tactile Systems Technology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Debt-to-Equity Chart

Tactile Systems Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.15

0.17

0.63

0.60

0.26

Tactile Systems Technology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.60	0.45	0.44	0.37	0.26

Competitive Comparison of Tactile Systems Technology's Debt-to-Equity

For the Medical Devices subindustry, Tactile Systems Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tactile Systems Technology's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's Debt-to-Equity falls into.

Tactile Systems Technology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tactile Systems Technology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.763	+	44.612)	/	193.642
	=	0.26

Tactile Systems Technology's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.763	+	44.612)	/	193.642
	=	0.26

Tactile Systems Technology (NAS:TCMD) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tactile Systems Technology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tactile Systems Technology (Tactile Systems Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

3L3:Germany

Address

3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website

https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Executives

Boyd Vindell Washington	director	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers	director, officer: President and CEO	INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler	officer: Senior VP, Sales	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke	director	3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns	officer: Sr. VP Mktg & Clinical Affairs	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls	officer: Senior VP, Sales	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer	officer: Chief Financial Officer	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen	officer: Chief Financial Officer	3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe	officer: Vice President, Sales	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys	director, officer: Chief Executive Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413